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ABSTRACT 
A practical, convenient, and safe cyano(nitro)methylation method was developed, in which 
cyano-aci-nitroacetate served as a synthetic equivalent of anionic nitroacetonitrile. A control of the 
single/double Michael additions was achieved, which enabled the synthesis of unsymmetrical double 
Michael adducts. Moreover, the Michael adducts can be used as precursors of pyridine and 
naphthyridine frameworks. 
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INTRODUCTION 
Nitroacetonitrile (NAN), a methylene connected with a nitro and a cyano functionalities, is used as a 
cyano(nitro)methylation agent, which serves as a building block for the synthesis of versatile 
polyfunctionalized compounds.1,2 Indeed, several reactions of NAN have been reported, such as 
Knoevenagel condensation with a ketone/aldehyde, addition reactions to polar multiple bonds, and 
Michael addition.1-3 In spite of the great potential of NAN, it has not been widely used in organic 
syntheses because of its low thermodynamic stability and preparative methods for synthesizing this 
reagent suffer from somewhat troublesome manipulations and poor yield performance.4 Semenov 
overcame these drawbacks by using a two phase system, by which NAN is prepared in good yield.5 
However, Thomas recently alerted on the explosive property of the NAN.6 In this context, the 
development of a safe alternative cyano(nitro)methylation agent is required.  
Meanwhile, we have reported that the pyridinium salt of nitroisoxazolone 1 undergoes the ring 
opening reaction quantitatively under mild conditions upon treatment with pyrrolidine (2A) to give 
dianionic cyano-aci-nitroacetate 3, which possesses three different functional groups on the same 
carbon atom (Scheme 1).7 The dianion 3 is thermally stable and is very soluble in common organic 
solvents, such as benzene, chloroform and ethanol. Since the dianion 3 is regarded as the masked 
framework of NAN, the above-mentioned features enabled its use as the easily treatable synthetic 
equivalent of the anionic forma of NAN accompanied by decarboxylation. Indeed, the dianion 3 
reacts with ketones and aldehydes to afford polyfunctionalized nitriles, such as glutaronitriles,7a 
a-nitro-a,b-unsaturated nitriles7a and a-nitro-d-keto nitrile.7b Herein we provide a new synthetic 
protocol for d-functionalized a-nitronitriles 5 and 6 by a Michael addition reaction of 
cyano-aci-nitroacetate 3 to functionalized alkenes 4. Additionally, we also demonstrate a single step 
conversion of the Michael adduct to a pyridine and a naphthyridine frameworks using the 
polyfunctionality of the Michael adducts.  
 
 Scheme 1 Generation of cyano-aci-nitroacetate 3 derived from nitroisoxazolone 1. 
 
RESULTS AND DISCUSSION 
Initially, the reaction of dianion 3 with 3-buten-2-one (4a) was chosen as a model reaction, and 
N-methylpyrrolidine (2B) was used as a base instead of 2A to avoid the undesired Michael addition 
reaction of the amine to 4a (Scheme 2). When the dianion 3 was subjected to reaction with equimolar 
4a in acetonitrile at 30 °C for 2 h, both single and double Michael adducts 5a8 and 6aa9 were 
obtained in 35 and 38% yields, respectively (Table 1, entry 1). In order to control the single/double 
Michael additions, the solvent, reaction time, and temperature were investigated (Table 1). Although 
the reaction proceeded efficiently in either nonpolar benzene or polar ethanol, the ratio of 5a/6aa was 
not affected by the polarity of the solvent (entries 2-3). Chloroform was found to be somewhat 
effective for the predominant single addition; however, all attempts for complete synthesis of the 
single Michael adduct 5a failed (entries 5-8). To our great surprise, the single Michael adduct 5a was 
obtained as a sole product when 2A was used as a base (entry 9). This suppression of the second 
Michael addition is probably due to the competitive Michael addition of 2A, and the adduct releases 
4a gradually under equilibrium, which keeps the concentration of 4a low in the reaction mixture 
(Scheme 2).10 On the other hand, double adduct 6aa was exclusively obtained in 94% yield by using 
5 equivalents of 4a. Consequently, the control of the single/double Michael addition was successfully 
achieved. 
 
 
Table 1 Optimization of the reaction conditions for Michael addition of cyano-aci-nitroacetate 3 to 
3-buten-2-one (4a). 
 
a Determined by 1H NMR. b Based on 4a. c Five equivalents of 4a were used. 
 
 
 
Entry Amine Solv. Temp. / °C 
Time 
/ h 
Yield /%a,b Ratio 
Total 5a 6aa 5a:6aa 
 1 2B MeCN 30 2  73  35 38 48:52 
 2 2B PhH 30 2 100  40 60 40:60 
 3 2B EtOH 30 2  93  40 52 44:56 
 4 2B CHCl3 30 2 100  56 44 56:44 
 5 2B CHCl3 30  0.5  56  38 18 68:32 
 6 2B CHCl3 30 6 100  57 43 57:43 
 7 2B CHCl3  0 2  39  19 20 49:51 
 8 2B CHCl3 60 2 100  61 39 61:39 
 9 2A CHCl3 30 2 100 >99 – 100:0 
10c 2B CHCl3 50 2  94 – 94   0:100 
 Scheme 2 A plausible mechanism of reaction of 4a and 3 using pyrrolidine 2A as a base. 
 
 
To explore the scope and limitations of the Michael addition reaction of 3, various Michael 
acceptors were employed. The cyclic enone 4b, the aromatic enones 4c and 4d, methyl crotonate 4e, 
and the nitrostyrene 4f underwent Michael additions to afford the corresponding single adducts 5b-f 
in high to excellent yields without any detectable double adducts 6bb-ff (Table 2, entries 1-5). These 
results suggested the substituent at the b-position of Michael acceptors suppressed the second 
Michael addition reaction. It can be attributed to the bulkiness of the counter cation which presents 
nearby the single adduct intermediate 5’ (Scheme 3). On the other hand, the reaction of 3 with 
methyl acrylate 4g, which has no substituent at the b-position, gave the double adduct 6gg in 9% 
yield besides the single adduct 5g (49%) (entry 6). As expected, the double adduct 6gg was afforded 
in 82% yield as a sole product upon treatment of 3 with 5 equivalents of 4g (entry 7). In the case of 
the dibenzylideneacetone 4h, functionalized cyclohexanone 6hh11 was obtained in 84% yield (entry 
8).	  
 
 
 
 
Table 2 Reaction of cyano-aci-nitroacetate 3 to Michael acceptors 4b-h. 
 
Entry Substrates 4 Eq. Temp. /°C Time /h Products 5 Yield /%a,b 
1 
 
1.0 60 4 
 
>99% 
dr = 1:1 
2 
 
1.0 60 20 
 
87% 
dr = 5:1 
3 
 
1.0 40 20 
 
78% 
dr = 1.7:1 
4 
 
5.0 80 24 
 
61% 
dr = 1.5:1 
5 
 
1.0 50 12 
 
75%f 
dr = 1.3:1 
6 
 
1.0 50 24 
 
49% 
(6gg, 9%) 
7 
 
5.0 60 24 
 
82% 
(5g, 0%) 
8 
 
1.0 80 24 
 
81%g 
a Isolated yield. The diastereomers were not separable, and this represents the total yield.  b The diastereomeric 
ratio was determined by 1H NMR of the crude product. c Tol: 4-MeC6H4. d Py: 2-Pyridyl. e Ethanol was used as 
a solvent. f The yield was determined by 1H NMR analysis using 1,1,2,2-tetrachloroethane as an internal 
standard without isolation of 5f because of its instability. g Isolated yield for cis isomer after purified by 
recrystallization.  
 
 
Scheme 3 Steric hindrance of the Michael acceptor preventing the second addition. 
As mentioned above, double Michael adduct 6bb was not detected even under the severe 
conditions; employing the excess amounts of 4b, higher temperature (>150 °C), and longer reaction 
time (48 h). Contrary to this, double adduct 6bb was obtained quantitatively, when a mixture of 
isolated single adduct 5b and the excess amounts of 4b was left standing without solvent at ambient 
temperature for 24 h even in the absence of an amine (Scheme 4, right). This is probably because the 
congestion around the active methine group is relieved by the removal of the counter cation through 
acidification (Scheme 3). This interesting result encouraged us to investigate the synthesis of an 
unsymmetrical double Michael adducts. Indeed, desired unsymmetric double Michael adducts 6ab 
were obtained in high yield (Scheme 4, left). 
 
Scheme 4 Reaction of single adduct 5b to Michael acceptors 4a,b. 
  
Both the single and double Michael adducts are useful synthetic precursors due to their 
polyfunctionality. For example, single adduct 5a, which has both an acidic hydrogen and an 
appropriate functionality, can be used as a substrate for the pseudo-intramolecular process.12 Indeed, 
63% of 2-amino-3-nitropyridine 712 was formed when a mixture of keto nitrile 5a and 2 equivalents 
of benzylamine in acetonitrile was heated in a sealed tube at 120 °C for 12 h (Scheme 5).13 The 
reaction proceeds in a similar manner to the dihydropyridine synthesis, reported previously.12 The 
ammonium salt, immediately formed upon treatment of the single adduct 5a with an amine, liberates 
the amine under equilibrium. In this stage, the amine is in close proximity to the cyano group of 5a 
(intimate pair), and attacks the cyano group to construct a six-membered ring as a result of the 
tandem cyclization. The subsequent dehydration and air oxidation gives 2-amino-3-nitropyridine 7.13  
 
Scheme 5 Synthesis of vicinally functionalized pyridine 7 from single adduct 5a via 
pseudo-intramolecular process. 
  
 
Additionally, the double Michael adduct 6aa provided 2,7-dimethyl-[1,8]-naphthyridine (8a)14 in 
61% yields upon heating with 5 equivalents of ammonium acetate in acetonitrile at 120 °C for 12 h. 
A plausible mechanism is also depicted in Scheme 6. The reaction between the two carbonyl groups 
with ammonium acetate gives the intermediate enamine 9, an intramolecular double cyclization 
followed by aromatization to give the product 8a. To enhance the utility of this method, we also 
examined the synthesis of [1,8]-naphthyridine from the pyridinium salt of isoxazolone 1 and Michael 
acceptor 4a without purification of the double Michael adduct (Scheme 7). After normal workup of 
Michael addition reaction, the residue was heated with 5 equivalents of NH4OAc to afford 
[1,8]-naphthyridine 8a in 45% overall yield. This method was also applicable to benzoyl ethene 4i 
(R1=R2=H, EWG=PhCO) leading to 2,7-diphenylnaphthyridine 8i14 directly with 56% yield. The 
[1,8]-naphthyridine skeleton is widely found in a biologically active substances16 and used as a 
ligand for many metal complexes.17 This reaction is highly useful because the naphthyridine skeleton 
is constructed in a single step which was not easily achieved by conventional methods.18, 19 
Additionally, this method is multi-component reaction which also fits the idea of highly efficient 
green synthesis methodology.20 
 
 
 Scheme 6 A concise construction of [1,8]-naphthridine 8 via double cyclization/aromatization 
procedure from diketone 6aa. 
 
 
 
Scheme 7 Synthesis of [1,8]-naphthridine 8 from the pyridinium salt of nitroisoxazolone 1. 
 
CONCLUSIONS 
In conclusion, we have demonstrated cyano-aci-nitroacetate 3 derived from nitroisoxazolone 1 can 
be regarded as a practically usable and safe cyano(nitro)methylation agent, which reacts with 
Michael acceptors 4 to afford both single/double adducts 5 and 6. In addition, the synthesis of an 
unsymmetrical double Michael adduct 6ab was demonstrated through the reaction of isolated single 
adduct 5b with Michael acceptor 4a without solvent. As one of the applications of the single Michael 
adduct 5a, polyfunctionalized pyridine 7 was easily prepared in good yield via a 
pseudo-intramolecular process. Additionally, the concise, double Michael addition reaction, followed 
by intramolecular double cyclization reaction upon treatment with ammonium acetate was 
successfully achieved to afford [1,8]-naphthyridine 8.  
 
EXPERIMENTAL SECTION 
Typical Procedure for Michael Addition Reaction of Cyano-aci-nitroacetate with Michael 
Acceptor 4. To a solution of pyridinium salt 1 (0.25 mmol) in chloroform (2 mL), amine 2B (0.5 
mmol) was added and the resultant mixture was stirred several minutes until the salt was completely 
dissolved. And then Michael acceptor 4 was added. After stirring of the solution for 4 h at 30 °C, 1M 
HCl solution (1.5 mL) was added, and extracted with chloroform (2 × 5 mL). The combined organic 
layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The yield and 
diastereomer ratio of the product were determined by 1H NMR integration of the crude product using 
1,1,2,2-tetrachloroethane as an internal standard. Further purification was achieved by flash column 
chromatography on silica gel (hexane/EtOAc = 95/5). All products were isolated in almost pure form 
but not stable to the elemental analysis. 
3-(Cyanonitromethyl)cyclohexan-1-one (5b): (46.0 mg, >99%); (1:1 diastereomer mixture), 
yellow oil. Diastereomer A:1H NMR (400 MHz, CDCl3) δ 1.80–1.64 (m, 2H), 2.10–1.91 (m, 1H), 
2.21–2.17 (m, 1H), 2.51–2.20 (m, 4H), 2.98–2.80 (m, 1H), 5.36 (d, J = 5.2 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 23.6 (CH2), 26.2 (CH2), 40.5 (CH2), 40.9 (CH), 42.2 (CH2), 80.4 (CH), 110.4 (C), 
206.1 (C); Diastereomer B:1H NMR (400 MHz, CDCl3) δ 1.80–1.64 (m, 2H), 2.10–1.91 (m, 1H), 
2.21–2.17 (m, 1H), 2.51–2.20 (m, 4H), 2.98–2.80 (m, 1H), 5.27 (d, J = 5.2 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 23.8 (CH2), 27.4 (CH2), 40.4 (CH2), 40.9 (CH), 43.3 (CH2), 80.3 (CH), 110.5 (C), 
206.1 (C); IR (neat) 1715, 1568, 1350 cm-1. HRMS (CI, Magnetic field) m/z calcd. for C8H11N2O3: 
183.0770 (M + H) +, found 183.0770. 
3-Cyanonitromethyl-1,3-bis(4-methylphenyl)-1-propanone (5c): (70.8 mg, 87%); (5:1 
diastereomer mixture), white solid, mp 126–127 °C. Major isomer: 1H NMR (400 MHz, CDCl3) δ 
2.34 (s, 3H), 2.43 (s, 3H), 3.57–3.68 (m, 2H), 4.40–4.45 (m, 1H), 6.20 (d, J = 5.2 Hz 1H), 7.17–7.19 
(m, 2H), 7.22–7.30 (m, 4H), 7.83–7.87 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 21.1 (CH3), 21.7 
(CH3), 40.1 (CH), 42.3 (CH2), 80.3 (CH), 110.9 (C), 128.0 (CH), 128.2 (CH), 129.5 (CH), 130.1 
(CH), 131.8 (C), 133.3 (C), 139.2 (C), 145.2 (C), 195.7 (C); Minor isomer: 1H NMR (400 MHz, 
CDCl3) δ 2.33 (s, 3H), 2.42 (s, 3H), 3.57–3.70 (m, 2H), 4.40–4.45 (m, 1H), 5.75 (d, J = 5.2 Hz 1H), 
7.19–7.22 (m, 2H), 7.24–7.30 (m, 4H), 7.83–7.85 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 21.1 
(CH3), 21.7 (CH3), 38.9 (CH), 43.3 (CH2), 80.2 (CH), 111.3 (C), 127.8 (CH), 128.2 (CH), 129.6 
(CH), 130.0 (CH), 132.2 (C), 133.6 (C), 139.1 (C), 144.9 (C), 195.6 (C); IR (KBr) 1684, 1572, 1410 
cm-1. HRMS (CI, Magnetic field) m/z calcd. for C19H19N2O3: 323.1396 (M + H) +, found 323.1394. 
3-Cyanonitromethyl-1-(2-pyridyl)-3-phenyl-1-propanone (5d): (57.5 mg, 78%); (1.7:1 
diastereomer mixture), yellow oil (The isolated product was easily decomposed by heating over 
60 °C). Major isomer: 1H NMR (400 MHz, CDCl3) δ 3.88 (dd, J = 9.2, 19.1 Hz, 1H), 4.07 (dd, J = 
5.0, 19.1 Hz, 1H), 4.44 (ddd, J = 5.0, 5.7, 9.2 Hz 1H), 6.10 (d, J = 5.7 Hz, 1H), 7.33–7.40 (m, 5H), 
7.51–7.53 (m, 1H), 7.82–7.85 (m, 1H), 8.02 (d, J = 7.8 Hz, 1H), 8.67–8.69 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 39.5 (CH2), 42.8 (CH), 80.4 (CH), 110.8 (C), 122.0 (CH), 128.0 (CH), 128.2 (CH), 
129.2 (CH), 129.2 (CH), 134.9 (C), 137.2 (CH), 149.2 (CH), 152.2 (C), 198.4 (C); Minor isomer: 1H 
NMR (400 MHz, CDCl3) δ 3.88 (dd, J = 6.7, 18.6 Hz, 1H), 4.18 (dd, J = 8.0, 18.6 Hz, 1H), 4.44 (ddd, 
J = 5.5, 6.7, 8.0 Hz 1H), 5.70 (d, J = 5.5 Hz, 1H), 7.33–7.40 (m, 5H), 7.51–7.53 (m, 1H), 7.82–7.85 
(m, 1H), 7.98 (d, J = 7.8 Hz, 1H), 8.67–8.69 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 38.4 (CH2), 
43.6 (CH), 80.6 (CH), 111.3 (C), 122.0 (CH), 127.8 (CH), 128.1 (CH), 129.0 (CH), 129.4 (CH), 
135.4 (C), 137.1 (CH), 149.1 (CH), 152.3 (C), 197.7 (C); IR (neat) 1691, 1571, 1396 cm-1. HRMS 
(CI, Magnetic field) m/z calcd. for C16H14N3O3: 296.1035 (M + H) +, found 296.1033.  
Methyl 4-cyano-3-methyl-4-nitrobutanoate (5e): (28.5 mg, 61%); (1.5:1 diastereomer mixture), 
yellow oil. Major isomer: 1H NMR (400 MHz, CDCl3) δ 1.19 (d, J = 6.8 Hz, 3H), 2.48–2.56 (m, 2H), 
3.09–3.16 (m, 1H), 3.73 (s, 3H), 5.84 (d, J = 4.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 15.4 (CH3), 
33.6 (CH), 36.6 (CH2), 52.4 (CH3), 80.2 (CH), 110.5 (C), 171.1 (C); Minor isomer: 1H NMR (400 
MHz, CDCl3) δ 1.25 (d, J = 6.9 Hz, 3H), 2.54–2.66 (m, 2H), 2.97–3.02 (m, 1H), 3.72 (s, 3H), 5.59 (d, 
J = 5.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 16.1 (CH3), 34.2 (CH), 36.1 (CH2), 52.3 (CH3), 80.2 
(CH), 111.3 (C), 171.0 (C); IR (neat) 1730, 1580, 1337 cm-1. HRMS (CI, Magnetic field) m/z calcd. 
for C7H11N2O4: 187.0719 (M + H) +, found 187.0722. 
2,4-Dinitro-3-phenylbutanenitrile (5f): (NMR yield, 75%); (1.3:1 diastereomer mixture), yellow 
oil. Major isomer: 1H NMR (400 MHz, CDCl3) δ 4.56–4.62 (m, 1H), 4.86–5.00 (m, 1H), 5.01–5.05 
(m, 1H), 5.96 (d, J = 5.6 Hz, 1H), 7.25–7.31 (m, 2H), 7.40–7.44 (m, 3H); 13C NMR (100 MHz, 
CDCl3) δ 44.8 (CH), 74.6 (CH2), 78.3 (CH), 109.9 (C), 128.0 (CH), 129.9 (CH), 130.3 (C), 130.4 
(CH). Minor isomer; 1H NMR (400 MHz, CDCl3) δ 4.48–4.51 (m, 1H), 4.86–5.00 (m, 1H), 
5.01–5.05 (m, 1H), 5.76 (d, J = 5.6 Hz, 1H), 7.25–7.31 (m, 2H), 7.40–7.44 (m, 3H); 13C NMR (100 
MHz, CDCl3) δ 45.3 (CH), 74.4 (CH2), 78.1 (CH), 110.3 (C), 127.7 (CH), 130.0 (CH), 130.3 (CH), 
130.8 (C). Satisfactory analytical data were not given because of the instability of 5f.  
Methyl 4-cyano-4-nitro-butanoate (5g): (21.2 mg, 49%); brown oil. 1H NMR (400 MHz, CDCl3) 
δ 2.54–2.71 (m, 4H), 3.73 (s, 3H), 5.59 (t, J = 7.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 27.6 
(CH2), 28.9 (CH2), 52.5 (CH3), 74.8 (CH), 111.7 (C), 171.4 (C); IR (neat) 1738, 1601, 1370 cm-1. 
HRMS (CI, Magnetic field) m/z calcd. for C6H9N2O4 : 173.0562 (M + H) +, found 173.0563.  
5-Cyano-5-nitro-nonane-2,8-dione (6aa): (53.3 mg, 94%); white solid, mp 77–78 °C (from 
hexane/chloroform). 1H NMR (400 MHz, CDCl3) δ 2.18 (s, 6H), 2.36–2.47 (m, 2H), 2.48–2.61 (m, 
4H), 2.71–2.81 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 30.0 (CH3), 32.4 (CH2), 38.1 (CH2), 88.9 
(C), 113.8 (C), 204.1 (C); IR (KBr) 1703, 1560, 1370 cm-1. HRMS (CI, Magnetic field) m/z calcd. 
for C10H15N2O4: 227.1032 (M + H) +, found 227.1033.  
Dimethyl 4-cyano-4-nitro-heptanedioate (6gg): (53.0 mg, 82%); yellow solid, mp 33–34 °C. 1H 
NMR (400 MHz, CDCl3) δ 2.39–2.54 (m, 4H), 2.61–2.71 (m, 4H), 3.72 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 29.2 (CH2), 33.7 (CH2), 52.5 (CH3), 88.5 (C), 113.3 (C), 170.8 (C); IR (KBr) 1738, 1568, 
1381 cm-1. HRMS (CI, Magnetic field) m/z calcd. for C10H15N2O6: 259.0930 (M + H) +, found 
259.0931.  
cis-4-Cyano-4-nitro-3,5-diphenylcyclohexanone (6hh): After workup, 13:1 of cis:trans mixture 
was obtained and cis isomer was isolated by recrystallization from hexane/chloroform (64.9 mg, 
81%); brown solid, mp 177–178 °C. 1H NMR (400 MHz, CDCl3) δ 2.89 (dd, J = 4.0, 15.6 Hz, 2H), 
3.32 (dd, J = 14.5, 15.6 Hz, 2H), 4.08 (dd, J = 4.0, 14.5 Hz, 2H), 7.33–7.37 (m, 2H), 7.38–7.40 (m, 
8H); 13C NMR (100 MHz, CDCl3) δ 43.7 (CH2), 50.5 (CH), 97.5 (C), 111.5 (C), 128.1 (CH), 129.6 
(CH), 130.0 (CH), 133.4 (C), 202.3 (C); IR (KBr) 1717, 1563, 1361 cm-1. HRMS (CI, Magnetic 
field) m/z calcd. for C19H17N2O3: 321.1239 (M + H) +, found 321.1240.  
Typical Procedure for Michael Addition Reaction of Single Adduct 5b with 4a,b. To a single 
adduct 5b (0.25 mmol), Michael acceptor 4 (0.3 mmol) was added. The resulting mixture was stirred 
for 24 h at 60 °C, and unreacted Michael acceptor was evaporated under vacuo to afford pure double 
adduct 6. Further purification was performed by recrystallization from hexane/chloroform. 
3-(1-Cyano-1-nitro-4-oxopentyl)-cyclohexanone (6ab): (53.1 mg, 84%); (1:1 diastereomer 
mixture), white solid, mp 124–125 °C. Diastereomer A: 1H NMR (400 MHz, CDCl3) δ 1.60–1.77 (m, 
2H), 2.17 (s, 3H), 2.14–2.78 (m, 11H); 13C NMR (100 MHz, CDCl3) δ 23.8 (CH2), 26.4 (CH2), 30.0 
(CH3), 30.3 (CH2), 38.1 (CH2), 40.4 (CH2), 42.5 (CH2), 45.6 (CH), 93.8 (C), 112.8 (C), 204.2 (C), 
206.0 (C); Diastereomer B: 1H NMR (400 MHz, CDCl3) δ 1.60–1.77 (m, 2H), 2.15 (s, 3H), 
2.14–2.78 (m, 11H); 13C NMR (100 MHz, CDCl3) δ 23.5 (CH2), 26.5 (CH2), 30.0 (CH3), 30.3 (CH2), 
38.0 (CH2), 40.5 (CH2), 42.3 (CH2), 45.5 (CH), 93.9 (C), 112.6 (C), 204.0 (C), 206.1 (C); IR (KBr) 
1713, 1562, 1355 cm-1. HRMS (CI, Magnetic field) m/z calcd. for C19H15Cl2NO: 343.0531 (M + H) +, 
found 343.0534.  
Cyanonitro-di-(3-oxochclohexyl)methane (6bb): (70.1 mg, >99%); pale yellow solid, mp 
145–146 °C. 1H NMR (400 MHz, CDCl3) δ 1.45–1.61 (m, 1H), 1.62–1.83 (m, 3H), 1.84–1.95 (m, 
1H), 2.15–2.38 (m, 7H), 2.44–2.65 (m, 3H), 2.68–2.78 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 23.7 
(CH2), 23.8 (CH2), 26.1 (CH2), 27.0 (CH2), 40.6 (CH), 40.7 (CH), 41.1 (CH2), 41.9 (CH2), 42.3 
(CH2), 42.5 (CH2), 97.2 (C), 112.9 (C), 205.6 (C), 205.7 (C); IR (KBr) 1715, 1562, 1348 cm-1. 
HRMS (CI, Magnetic field) m/z calcd. for C14H19N2O4: 279.1345 (M + H) +, found 279.1344.  
Procedure for the Synthesis of 2-amino-3-nitropyridine 7. To a solution of single adduct 5b (0.25 
mmol) in acetonitrile (3 mL), benzylamine (0.5 mmol) was added, and heated at 120 °C in a sealed 
tube for 12 h. After removal of the solvent, the residue was treated with column chromatography on 
silica gel to afford 2-amino-3-nitropyridine 7 (38.2 mg, 63%, eluted with dichloromethane). The 
product 7 was identified by comparison of spectral data with authentic sample. 
Synthesis of [1,8]-naphthyridine 8 from Double Michael Adduct 6. To a solution of double adduct 
6aa (0.20 mmol) in acetonitrile (3 mL), ammonium acetate (1.0 mmol) was added, and heated at 
120 °C in a sealed tube for 12 h. After removal of the solvent, the residue was treated with column 
chromatography on silica gel to afford [1,8]-naphthyridine 8a14 (19.4 mg, 61%, eluted with 
hexane/EtOAc = 80/20). The product 8a was identified by comparison of NMR spectra to those 
reported in the literature. 
Synthesis of [1,8]-naphthyridine 8 from Pyridinium Salt 1. To a solution of pyridinium salt 1 
(0.25 mmol) in chloroform (2 mL), amine (0.5 mmol) was added and the resultant mixture was 
stirred several minutes until the salt was completely dissolved. And then Michael acceptor 4 (1.3 
mmol) was added. After stirring of the solution for 4 h at 30 °C, 1M HCl solution (1.5 mL) was 
added, and extracted with chloroform (2 × 5 mL). The combined organic layer were dried over 
MgSO4, filtered, and evaporated to give double Michael adduct 6 which was used for the next step 
without purification. The solution of 6 in acetonitrile (3 mL), ammonium acetate (1.25 mmol) was 
added. The mixture was stirred at 120 °C in a sealed tube for 12 h. After removal of the solvent, the 
residue was treated with column chromatography on silica gel to afford [1,8]-naphthyridine 8a14 
(17.8 mg, 45%, eluted with hexane/EtOAc = 80/20) and 8i15 (39.5 mg, 56%, eluted with 
hexane/EtOAc = 80/20), respectively. The product 8i was identified by comparison of NMR spectra 
to those reported in the literature. 
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